Send to

Choose Destination
See comment in PubMed Commons below
Semin Cell Dev Biol. 2014 Apr;28:96-103. doi: 10.1016/j.semcdb.2014.03.023. Epub 2014 Mar 28.

JAK/STAT pathway dysregulation in tumors: a Drosophila perspective.

Author information

Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, 550 First Avenue, MSB 497B, New York, NY 10016, USA.
The Helen L. and Martin S. Kimmel Center for Stem Cell Biology, New York University School of Medicine. Electronic address:


Sustained activation of the JAK/STAT pathway is causal to human cancers. This pathway is less complex in Drosophila, and its dysregulation has been linked to several tumor models in this organism. Here, we discuss models of metastatic epithelial and hematopoietic tumors that are causally linked to dysregulation of JAK/STAT signaling in Drosophila. First, we focus on cancer models in imaginal discs where ectopic expression of the JAK/STAT pathway ligand Unpaired downstream of distinct tumor suppressors has emerged as an unexpected mediator of neoplastic transformation. We also discuss the collaboration between STAT and oncogenic Ras in epithelial transformation. Second, we examine hematopoietic tumors, where mutations that cause hyperactive JAK/STAT signaling are necessary and sufficient for "fly leukemia". We highlight the important contributions that genetic screens in Drosophila have made to understanding the JAK/STAT pathway, its developmental roles, and how its function is co-opted during tumorigenesis.


Carcinoma; Chinmo; Dome; ESCRT; Hop; Imaginal discs; JAK/STAT; Melanotic tumors; Myeloproliferative neoplasms; Notch; PRC1; Ras; Scribbled; Socs36E; Stat92E; T42; Tum-l; Upd; dPIAS

[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center